InterOcean Capital Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$948K Sell
2,843
-496
-15% -$152K 0.02% 217
2023
Q4
$904K Buy
3,339
+128
+4% +$31.6K 0.02% 209
2023
Q3
$790K Buy
3,211
+80
+3% +$21.9K 0.02% 215
2023
Q2
$950K Hold
3,131
0.03% 191
2023
Q1
$826K Buy
3,131
+2,000
+177% +$508K 0.03% 204
2022
Q4
$271K Hold
1,131
0.01% 342
2022
Q3
$208K Buy
+1,131
New +$225K 0.01% 366
2022
Q2
Sell
-950
Closed -$238K 430
2022
Q1
$238K Hold
950
0.01% 245
2021
Q4
$244K Hold
950
0.01% 232
2021
Q3
$231K Buy
+950
New +$232K 0.01% 222

Other funds holding HCA

InterOcean Capital Group's HCA Position: Q1 2024 in Review

InterOcean Capital Group reduced its HCA Healthcare (HCA) stake by 15% in Q1 2024, selling an estimated $152K and leaving 2,843 shares worth $948K. The position accounts for 0.02% of the portfolio, ranked #217.

InterOcean Capital Group first reported a position in HCA in Q3 2021 and has held it in 10 quarters since. The position peaked at $950K in Q2 2023. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

  • InterOcean Capital Group held 2,843 shares of HCA Healthcare worth $948K as of Q1 2024.
  • InterOcean Capital Group sold 496 HCA Healthcare shares in Q1 2024, an estimated $152K.
  • HCA Healthcare made up 0.02% of InterOcean Capital Group's portfolio in Q1 2024, its #217 holding.
  • InterOcean Capital Group first reported a position in HCA Healthcare in Q3 2021 and has held it in 10 quarters since.
  • InterOcean Capital Group's HCA Healthcare position peaked at $950K in Q2 2023.
  • 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.